Welcome to Action Kidney Cancer

The United Kingdom’s only patient-led kidney cancer charity

Help & support

Community Forum

Stronger together

Join now

In our own words

During this series of videos, kidney cancer patients and carers talk frankly about their experiences, emotions and how to live well with a diagnosis of kidney cancer
Coping with a diagnosis of kidney cancer
Talking about kidney cancer
A carer’s perspective
Watch all

Real stories

The lives of all these people have been affected by kidney cancer
Some are patients, some are carers, all are stories by real people sharing their experiences of living with kidney cancer
Read real stories

Latest kidney cancer news

3 Oct 2022

A modified nivolumab/ipilimumab dosing regimen

3 Oct 2022

C-reactive protein as a potential biomarker of effectiveness of avelumab plus axitinib in people with advanced kidney cancer

26 Sep 2022

Government's new Health and Social Care Plan

26 Sep 2022

Adjuvant pembrolizumab approved by NICE

23 Sep 2022

Telaglenastat plus cabozantinib in patients with metastatic kidney cancer

14 Sep 2022

ESMO 2022: Pembrolizumab plus lenvatinib shows promise for non clear cell kidney cancer

13 Sep 2022

ESMO 2022: Update of the lenvatinib plus pembrolizumab versus sunitinib study in patients with advanced kidney cancer

12 Sep 2022

COVID-19 vaccines, boosters and immunity webinar

12 Sep 2022

ESMO 2022: Atezolizumab as an adjuvant therapy

12 Sep 2022

ESMO 2022: Nivolumab before and after surgery to prevent recurrence of kidney cancer

9 Sep 2022

ESMO 2022: Combination of cabozantinib, nivolumab and ipilimumab for patients with advanced kidney cancer with high-risk disease

7 Sep 2022

Northern Soul fundraising event

Check all news
The first adjuvant treatment pembrolizumab has been approved for people with increased risk of their #kidneycancer returning after surgery in England and Wales on the NHS, by the National Institute for Health and Care Excellence
Read about the therapy:
https://t.co/iJpfD3zH8E https://t.co/Kc0Bp52mDt
ACTION4KC photo
Health and Social Care Secretary and Deputy Prime Minister, Thérèse Coffey sets out a plan for patients with new funding to bolster social care over the winter.
Read more on our website here: https://t.co/fEddu4ZGzD https://t.co/EOgAyxf6Qs
ACTION4KC photo
Now open! Along with @IKCCorg we have launched the 2022 Global Patient Survey! All #kidneycancer patients and carers are invited to share their experiences and insights in the online survey.
Find more on our website: https://t.co/tq5uNlvIZv https://t.co/sOiPQtzulE
ACTION4KC photo
This phase 2 CANTATA study compared telaglenastat plus cabozantinib with placebo plus cabozantinib in previously treated patients with clear-cell metastatic #kidneycancer.
To read about the study and outcomes:
https://t.co/redBIjPqCj

#bypatientsforpatients https://t.co/SdzXFMtTXG
ACTION4KC photo
In this phase 3, randomised study the immune system was stimulated with nivolumab before surgery followed by nivolumab after surgery in patients with high risk localised #kidneycancer. This was compared to surgery alone.
Read more: https://t.co/UbKgXJG63X https://t.co/9VPeG0hDTY
ACTION4KC photo
Follow on Twitter
Action Kidney Cancer
Action Kidney Cancer
This study looked at levels of a biomarker called C-reactive protein (CRP) in the blood to try to predict the effectiveness of a combination of avelumab plus axitinib in people with advanced kidney cancer.

Read more on our website here:https://actionkidneycancer.org/c-reactive-protein-as-a-potential-biomarker-of-effectiveness-of-avelumab-plus-axitinib-in-people-with-advanced-kidney-cancer/
Action Kidney Cancer
Action Kidney Cancer
Now open! Action Kidney Cancer and @IKCCorg have launched the 2022 Global Patient Survey! All #kidneycancer patients and carers are invited to share their experiences and insights in the online survey.
Find out more on our website: https://actionkidneycancer.org/.../2022-ikcc-global.../

#kidneycancer #bypatientsforpatients #StrongerTogether
Action Kidney Cancer
Action Kidney Cancer
Now open! Action Kidney Cancer and @IKCCorg have launched the 2022 Global Patient Survey! All #kidneycancer patients and carers are invited to share their experiences and insights in the online survey.
Find our more on our website: https://actionkidneycancer.org/.../2022-ikcc-global.../
Action Kidney Cancer
Action Kidney Cancer
Health and Social Care Secretary and Deputy Prime Minister, Thérèse Coffey sets out a plan for patients with new funding to bolster social care over the winter.
Read more on our website here: https://actionkidneycancer.org/governments-new-health-and-social-care-plan/
Action Kidney Cancer
Action Kidney Cancer
Now open! Action Kidney Cancer and @IKCCorg have launched the 2022 Global Patient Survey! All #kidneycancer patients and carers are invited to share their experiences and insights in the online survey.
Find our more on our website: https://actionkidneycancer.org/get-involved/2022-ikcc-global-patient-survey/
Action Kidney Cancer
Action Kidney Cancer
Late last week we learnt that the National Institute for Health and Care Excellence (NICE) approved pembrolizumab for the adjuvant treatment of people with increased risk of their kidney cancer returning after surgery (nephrectomy). This is the first adjuvant immunotherapy to be approved for use on the NHS in England and Wales.
Read more on our website here: https://actionkidneycancer.org/adjuvant-pembrolizumab-approved-by-nice/
Follow on Facebook